A Post-Marketing Surveillance Study on the Safety, Tolerability and Efficacy of Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus
A Post-Marketing Surveillance Study on the Safety, Tolerability and Efficacy of Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus
This is a prospective, non-interventional, open label, multi center, post marketing surveillance study designed to assess the safety, tolerability and efficacy of Linagliptin among Filipino patients with type 2 Diabetes Mellitus (DM) within the study duration of 24 weeks.
Inclusion criteria:
Exclusion criteria:
Agoo, La Union, Philippines
Angeles City, Pampanga, Philippines
Angono, Rizal, Philippines
Antipolo, Rizal, Philippines
Aparri, Cagayan, Philippines
Cardona, Rizal, Philippines
Dagupan, Pangasinan, Philippines
Lucena, Quezon, Philippines
Malolos, Bulacan, Philippines
Puerto Princesa, Palawan, Philippines
Rosales, Pangasinan, Philippines
San Fernando, La Union, Philippines
San Fernando, Pampanga, Philippines
San Pablo, Laguna, Philippines
San Pedro, Laguna, Philippines
Santiago City, Isabela, Philippines
Tagbilaran, Bohol, Philippines
Tuguegarao, Cagayan, Philippines
Urdaneta, Pangasinan, Philippines
Valencia City Bukidnon, Philippines
Valenzuela, Bulacan, Philippines